Asians who use angiotensin-converting enzyme inhibitors, fibrates, alpha-glucosidase inhibitors or insulin are likely to have cortical cataract, independent of the presence of hypertension, hyperlipidaemia or diabetes, according to data from the Singapore Epidemiology of Eye Diseases (SEED) study.
The fixed-dose combination of brinzolamide 1% and brimonidine 0.2% (BBFC) is superior to vehicle in lowering intraocular pressure (IOP) over a 24-hour period following 4 weeks of 3-times-daily treatment in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT), a study has shown.
A novel incentive strategy which rewards patients who are compliant to their medications significantly improves adherence rates, thus providing a potential cost-effective adherence intervention, the SIGMA* study shows.
Presenting and best-corrected bilateral visual impairment (VI) and blindness are uncommon among Singaporeans, according to a new study. Important risk factors include the Malay ethnicity and advanced age and cataracts.
A recent study by investigators from the Chinese University of Hong Kong (CUHK) showed that low-concentration atropine eye drops could reduce myopia progression in school children by up to nearly 70 percent.
Patients undergoing chemotherapy for breast or haematological cancers could potentially reduce their risk of chemotherapy-related cardiotoxicity with the use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists (ARBs), or beta-blockers as primary prevention, according to a systematic review and meta-analysis presented at the recent EuroEcho 2019 conference.
Use of isatuximab (Isa) in combination with pomalidomide and dexamethasone (PomDex) appears to lead to more favourable outcomes in elderly patients with relapsed/refractory multiple myeloma (RRMM) as compared with PomDex alone, according to the results of a subgroup analysis of the ICARIA-MM trial presented at the 61st Annual Meeting of the American Society of Hematology (ASH 2019).